Keywords: Tumors, Cancer, Glioma;True Progression;Pseudoprogression;DKI;IVIMThe differentiation of pseudoprogression from true progression remains a crucial diagnostic dilemma in glioma with postoperative radiation therapy.This work to explore the role of DKI combined IVIM in differentiating true progression and pseudoprogression in glioma. It was concluded that the MK and RK from DKI、D and D* from IVIM can be used as novel imaging biomarkers for Clinical and radiologists in differentiating glioma true progression from pseudoprogression. Combining MK, RK, D and D* may explore as an effective strategy to improve the ability for discriminating glioma true progression and pseudoprogression.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords